Alliance Pharmaceutical Corp. Report issue

Contributed to NME For profit Phase 1
Founded: La Jolla CA United States (1983)
Status: Acquired by Imcor (2002)

Organization Overview

First Clinical Trial
2015
NCT02392793
First Marketed Drug
1993
perflexane (Imagent)
First NDA Approval
1993
perfluorooctyl bromide (Imagent)
Last Known Activity
2022

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ALLIANCE PHARM | Alliance Pharma | Alliance Pharmaceuticals

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 6